UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...
UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
UiPath (PATH) has been a surprise winner in the software sector. The company has made great strides in integrating generative AI into its product suite, which I expect to boost the business’ traction ...